Padraig Mcdonnell Sells 1,958 Shares of Agilent Technologies, Inc. (NYSE:A) Stock

Agilent Technologies, Inc. (NYSE:AGet Free Report) CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the sale, the chief executive officer now owns 25,185 shares of the company’s stock, valued at approximately $3,274,050. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Agilent Technologies Stock Performance

Shares of A opened at $132.87 on Friday. The company’s fifty day moving average is $142.36 and its 200-day moving average is $137.67. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.35. The firm has a market cap of $38.77 billion, a price-to-earnings ratio of 31.41, a price-to-earnings-growth ratio of 4.44 and a beta of 1.07. The company has a quick ratio of 1.64, a current ratio of 2.15 and a debt-to-equity ratio of 0.34.

Agilent Technologies (NYSE:AGet Free Report) last announced its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the business posted $1.27 EPS. Agilent Technologies’s quarterly revenue was down 8.4% on a year-over-year basis. Equities analysts expect that Agilent Technologies, Inc. will post 5.25 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be paid a dividend of $0.236 per share. The ex-dividend date of this dividend is Tuesday, July 2nd. This represents a $0.94 annualized dividend and a dividend yield of 0.71%. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Analysts Set New Price Targets

Several equities research analysts recently commented on A shares. UBS Group reduced their price target on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating for the company in a research report on Thursday, May 30th. Citigroup reduced their price target on shares of Agilent Technologies from $145.00 to $135.00 and set a “neutral” rating for the company in a research report on Thursday, May 30th. Jefferies Financial Group restated a “hold” rating and issued a $135.00 price target (down previously from $152.00) on shares of Agilent Technologies in a research report on Monday. Evercore ISI cut their target price on shares of Agilent Technologies from $145.00 to $126.00 and set an “in-line” rating for the company in a research report on Thursday, May 30th. Finally, JPMorgan Chase & Co. cut their target price on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $136.50.

Get Our Latest Stock Analysis on A

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Agilent Technologies by 18.2% in the 1st quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company’s stock valued at $4,348,471,000 after buying an additional 4,605,228 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in Agilent Technologies by 19.6% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 13,246,489 shares of the medical research company’s stock valued at $1,841,659,000 after buying an additional 2,170,219 shares during the last quarter. Wellington Management Group LLP grew its stake in Agilent Technologies by 17.4% in the 3rd quarter. Wellington Management Group LLP now owns 10,255,526 shares of the medical research company’s stock valued at $1,146,773,000 after buying an additional 1,519,134 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Agilent Technologies by 13.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock valued at $1,242,956,000 after buying an additional 1,042,926 shares during the last quarter. Finally, Northern Trust Corp grew its position in Agilent Technologies by 6.6% in the 3rd quarter. Northern Trust Corp now owns 4,097,313 shares of the medical research company’s stock worth $458,162,000 after purchasing an additional 254,998 shares during the last quarter.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Articles

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.